Adtalem Global Education Inc(ATGE) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 14.51 | EPS (ttm) | 6.79 | Insider Own | 2.83% | Shs Outstand | 34.6M | Perf Week | 3.16% |
| Market Cap | 3.40B | Forward P/E | 10.88 | EPS next Y | 14.07% | Insider Trans | -5.44% | Shs Float | 33.5M | Perf Month | -19.01% |
| Enterprise Value | 4.06B | PEG | 0.65 | EPS next Q | 1.8 | Inst Own | 102.06% | Short Float | 4.45% | Perf Quarter | 2.86% |
| Income | 0.25B | P/S | 1.8 | EPS this Y | 18.99% | Inst Trans | -0.57% | Short Ratio | 2.9 | Perf Half Y | -25.85% |
| Sales | 1.89B | P/B | 2.48 | EPS next 5Y | 16.62% | ROA | 9.46% | Short Interest | 1.49M | Perf YTD | -4.76% |
| Book/sh | 39.79 | P/C | 46.94 | EPS past 3/5Y | - 10.18% | ROE | 17.92% | 52W High | -36.94% ($156.26) | Perf Year | 0.89% |
| Cash/sh | 2.1 | P/FCF | 9.24 | Sales past 3/5Y | 8.97% 11.19% | ROIC | 12.17% | 52W Low | 14.24% ($86.26) | Perf 3Y | 146.29% |
| Dividend Est. | - | EV/EBITDA | 8.79 | EPS Y/Y TTM | 26.43% | Gross Margin | 60.28% | Volatility(W/M) | 3.06% 4.92% | Perf 5Y | 142.59% |
| Dividend TTM | - | EV/Sales | 2.15 | Sales Y/Y TTM | 11.92% | Oper. Margin | 19.89% | ATR (14) | 4.25 | Perf 10Y | 452.66% |
| Dividend Ex-Date | 2016/11/30 | Quick Ratio | 0.68 | EPS Q/Q | 6.43% | Profit Margin | 13.37% | RSI (14) | 42.22 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.68 | Sales Q/Q | 12.43% | SMA20 | -3.68% ($102.3) | Beta | 0.72 | Target Price | $161 |
| Payout | - | Debt/Eq | 0.53 | Earnings | 2026/1/28 | SMA50 | -6.57% ($105.47) | Rel Volume | 1.33 | Prev Close | $96.64 |
| Employees | 10371 | LT Debt/Eq | 0.5 | EPS/Sales Surpr. | 11.09% 3% | SMA200 | -17.88% ($120) | Avg Volume(3M) | 0.51M | Price | $98.54 |
| IPO | 1991/6/21 | Option/Short | Yes/Yes | Trades | 7877 | Volume | 682,276 | Change | 1.97% |
🏥 Specializes in medical and healthcare education. Trains nurses, doctors, and pharmacists. 97,000 students. Has delivered growth for nine consecutive quarters, with adjusted EPS growth of 18%.
Over the past 1 year, on the lower side
37% below its 1-year high.
Traded more than usual. That is 133% of its average volume.
ATGE makes money but has a weak balance sheet
Of every $100 in sales, $19.89 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +19.0% this year.
Tap to view numbers
The price is about the industry average
For a company expected to earn $100 next year, you would pay $1,088. Peers typically go for $1,414.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +142.6%. The S&P 500 did +64% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 102.1%.
Tap to view numbers
It ranks #5 of 44 in the industry
Based on market cap of $3B.
FAQ
What kind of company is ATGE?
ATGE belongs to the Consumer Defensive sector and operates in the Education & Training Services industry.
What is the market cap of ATGE?
The market cap of ATGE is approximately $3.4B, ranking 1,647 within its sector.
What is the P/E ratio of ATGE?
ATGE has a P/E ratio of approximately 14.5x, which can be used to assess its valuation relative to the Consumer Defensive sector average.
What is the 52-week high and low for ATGE?
ATGE has recorded a 52-week high of $156.26 and a low of $86.26.